The Japanese Global Health Innovative Technology Fund said it will invest nearly $15 million to advance new drugs for neglected tropical diseases as well as…

Resistance to antibacterials is fast becoming one of the most urgent public health problems, especially since the pipeline for new antibiotics largely has…

With drug-resistant tuberculosis on the rise worldwide, the nonprofit Critical Path Institute has won an $11.8 million grant from the Bill & Melinda…

In an effort to help speed new drugs to market, the New York City-based Alzheimer's Drug Discovery Foundation and the U.K.'s Alzheimer'…

Dutch InteRNA Technologies is collaborating with the Neuroallianz Consortium, an academic industry partnership with Belgium-based UCB and the Rheinische…

After launching a subsidiary that will focus on vaccines in December, Astellas Pharma is showing that it's serious about becoming a player in the vaccines…

Cancer Research UK has struck a deal with AstraZeneca to repurpose an experimental therapy originally developed by the drug giant for asthma and study its…

GlaxoSmithKline is launching what it calls the Oncology Clinical and Translational Consortium (OCTC), a collaborative scientific research network intended to…